Sesen Bio, Inc. Insider Trading for September 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Sesen Bio, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Sesen Bio, Inc. for September 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30 2016 | EBIO | Eleven Biotherapeu ... | Celniker Abbie | Director | Sell | S | 3.00 | 10,031 | 30,093 | 409,915 | 419.9 K to 409.9 K (-2.39 %) |
| Sep 26 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.10 | 10,293 | 31,908 | 106,787 | 117.1 K to 106.8 K (-8.79 %) |
| Sep 26 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.10 | 41,178 | 127,652 | 426,885 | 468.1 K to 426.9 K (-8.80 %) |
| Sep 26 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.16 | 3,118 | 9,853 | 117,080 | 120.2 K to 117.1 K (-2.59 %) |
| Sep 26 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.16 | 12,482 | 39,443 | 468,063 | 480.5 K to 468.1 K (-2.60 %) |
| Sep 26 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.17 | 47,090 | 149,275 | 120,198 | 167.3 K to 120.2 K (-28.15 %) |
| Sep 26 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.17 | 188,367 | 597,123 | 480,545 | 668.9 K to 480.5 K (-28.16 %) |
| Sep 26 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.18 | 28,163 | 89,558 | 167,288 | 195.5 K to 167.3 K (-14.41 %) |
| Sep 26 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.18 | 112,731 | 358,485 | 668,912 | 781.6 K to 668.9 K (-14.42 %) |
| Sep 22 2016 | EBIO | Eleven Biotherapeu ... | DAN LESLIE | Director | Option Exercise | A | 3.37 | 16,143 | 54,402 | 16,143 | |
| Sep 22 2016 | EBIO | Eleven Biotherapeu ... | DAN LESLIE | Director | Grant | A | 0.00 | 3,582,328 | 0 | 3,582,328 | 0 to 3.6 M |
| Sep 22 2016 | EBIO | Eleven Biotherapeu ... | DeCillis Arthur | Chief Medical Offic ... | Option Exercise | A | 3.37 | 100,000 | 337,000 | 100,000 | |
| Sep 22 2016 | EBIO | Eleven Biotherapeu ... | HURLY STEPHEN A | President and CEO | Option Exercise | A | 3.37 | 350,000 | 1,179,500 | 350,000 | |
| Sep 22 2016 | EBIO | Eleven Biotherapeu ... | HURLY STEPHEN A | President and CEO | Grant | A | 0.00 | 398,031 | 0 | 398,031 | 0 to 398 K |
| Sep 22 2016 | EBIO | Eleven Biotherapeu ... | MCCABE JOHN J | Chief Financial Off ... | Option Exercise | A | 3.37 | 100,000 | 337,000 | 100,000 | |
| Sep 22 2016 | EBIO | Eleven Biotherapeu ... | MCCABE JOHN J | Chief Financial Off ... | Option Exercise | A | 0.28 | 6,664 | 1,866 | 20,000 | |
| Sep 22 2016 | EBIO | Eleven Biotherapeu ... | Celniker Abbie | Director | Option Exercise | A | 0.28 | 29,988 | 8,397 | 90,000 | |
| Sep 21 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.75 | 64,509 | 241,909 | 195,451 | 260 K to 195.5 K (-24.81 %) |
| Sep 21 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.75 | 258,214 | 968,303 | 781,643 | 1 M to 781.6 K (-24.83 %) |
| Sep 21 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.39 | 10,778 | 36,537 | 259,960 | 270.7 K to 260 K (-3.98 %) |
| Sep 21 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.39 | 43,139 | 146,241 | 1,039,857 | 1.1 M to 1 M (-3.98 %) |
| Sep 21 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.31 | 1,939 | 6,418 | 270,738 | 272.7 K to 270.7 K (-0.71 %) |
| Sep 21 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.31 | 7,761 | 25,689 | 1,082,996 | 1.1 M to 1.1 M (-0.71 %) |
| Sep 16 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 4.16 | 536 | 2,230 | 272,677 | 273.2 K to 272.7 K (-0.20 %) |
| Sep 16 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 4.16 | 2,145 | 8,923 | 1,090,757 | 1.1 M to 1.1 M (-0.20 %) |
| Sep 16 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 4.18 | 8,802 | 36,792 | 273,213 | 282 K to 273.2 K (-3.12 %) |
| Sep 16 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 4.18 | 35,209 | 147,174 | 1,092,902 | 1.1 M to 1.1 M (-3.12 %) |
| Sep 08 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 4.51 | 8,145 | 36,734 | 282,015 | 290.2 K to 282 K (-2.81 %) |
| Sep 08 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 4.51 | 32,597 | 147,012 | 1,128,111 | 1.2 M to 1.1 M (-2.81 %) |
| Sep 08 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 4.51 | 52,985 | 238,962 | 1,833,802 | 1.9 M to 1.8 M (-2.81 %) |
| Sep 08 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 4.63 | 3,108 | 14,390 | 290,160 | 293.3 K to 290.2 K (-1.06 %) |
| Sep 08 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 4.63 | 12,441 | 57,602 | 1,160,708 | 1.2 M to 1.2 M (-1.06 %) |
| Sep 08 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 4.63 | 20,221 | 93,623 | 1,886,787 | 1.9 M to 1.9 M (-1.06 %) |